Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(9%)
Results Posted
57%(4 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
4
36%
Ph phase_4
2
18%
Ph phase_1
1
9%
Ph not_applicable
2
18%

Phase Distribution

1

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
4(44.4%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
unknown2
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 34 (44.4%)
Phase 42 (22.2%)
N/A2 (22.2%)

Trials by Status

completed764%
terminated19%
unknown218%
active_not_recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11